Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta-analysis of randomized clinical trials.

Huang, I-Hsin; Wu, Po-Chien; Lee, Ya-Han; Kang, Yi-No

Huang, I-Hsin; Wu, Po-Chien; Lee, Ya-Han; Kang, Yi-No.

Affiliation

Huang IH; Department of General Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Wu PC; Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee YH; Evidence-Based Medicine Center, Wan Fang Hospital, Taipei Medical University, No. 111, Section 3, Xing-Long Road, Taipei, 11696, Taiwan.
Kang YN; Department of Pharmacy, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

Sci Rep ; 10(1): 18609, 2020 10 29.

Article de En | MEDLINE | ID: mdl-33122778

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Migraines / Anticorps monoclonaux Type d'étude: Clinical_trials / Etiology_studies / Systematic_reviews Limites: Humans Langue: En Journal: Sci Rep Année: 2020 Type de document: Article Pays d'affiliation: Taïwan Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google